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ABSTRACT
ObjectiveToassesswhethernon-polluting,moreeffective
home heating (heat pump, wood pellet burner, flued gas)
hasapositiveeffectonthehealthofchildrenwithasthma.
Design Randomised controlled trial.
Setting Households in five communities in New Zealand.
Participants 409 children aged 6-12 years with doctor
diagnosed asthma.
Interventions Installation of a non-polluting, more
effective home heater before winter. The control group
received a replacement heater at the end of the trial.
Main outcome measures The primary outcome was
change in lung function (peak expiratory flow rate and
forcedexpiratoryvolumeinonesecond,FEV1).Secondary
outcomes were child reported respiratory tract symptoms
anddailyuseofpreventerandrelieverdrugs.Attheendof
winter 2005 (baseline) and winter 2006 (follow-up)
parentsreportedtheirchild’sgeneralhealth,useofhealth
services, overall respiratory health, and housing
conditions. Nitrogen dioxide levels were measured
monthly for four months and temperatures in the living
room and child’s bedroom were recorded hourly.
Results Improvements in lung function were not
significant (difference in mean FEV1 130.7 ml, 95%
confidence interval −20.3 to 281.7). Compared with
children in the control group, however, children in the
intervention group had 1.80 fewer days off school (95%
confidence interval 0.11 to 3.13), 0.40 fewer visits to a
doctorforasthma(0.11to0.62),and0.25fewervisitstoa
pharmacist for asthma (0.09 to 0.32). Children in the
intervention group also had fewer reports of poor health
(adjusted odds ratio 0.48, 95% confidence interval 0.31
to 0.74), less sleep disturbed by wheezing (0.55, 0.35 to
0.85), less dry cough at night (0.52, 0.32 to 0.83), and
reducedscoresforlowerrespiratorytractsymptoms(0.77,
0.73 to 0.81) than children in the control group. The
interventionwasassociatedwithameantemperaturerise
inthelivingroomof1.10°C(95%confidenceinterval0.54°
C to 1.64°C) and in the child’s bedroom of 0.57°C (0.05°C
to 1.08°C). Lower levels of nitrogen dioxide were
measured in the living rooms of the intervention
households than in those of the control households
(geometric mean 8.5 μg/m
3v 15.7 μg/m
3, P<0.001). A
similar effect was found in the children’s bedrooms (7.3
μg/m
3v 10.9 μg/m
3, P<0.001).
Conclusion Installing non-polluting, more effective
heating in the homes of children with asthma did not
significantly improve lung function but did significantly
reduce symptoms of asthma, days off school, healthcare
utilisation, and visits to a pharmacist.
Trial registration Clinical Trials NCT00489762.
INTRODUCTION
Asthmaisoneofthemostprevalentchronicdiseasesin
childhood. In New Zealand about 25% of children
report symptoms of asthma, and asthma is the second
most common reason for children being admitted to
hospital.
1 As well as the stress associated with having a
chronicdisease,asthmacanleadtohigherutilisationof
health services and drug costs.
2 Children with asthma
are likely to have more days off school, with adverse
effectsonacademicperformance,
3andtheircaregivers
may lose significant time from work.
4
Evidenceisgrowingthatsymptomsofasthmacanbe
aggravated or triggered by adverse aspects of the
indoorenvironment.
56Evidencefromstudiesofexcess
morbidity and mortality during winter in temperate
climates shows that temperatures in many homes are
below the levels recommended by the World Health
Organization for maintaining health in vulnerable
populations.
7 This is the case in New Zealand, where
homeheatingseemsnottobetreatedasanecessitylike
it is in the cooler parts of continental Europe.
7-9
As well as cold temperatures, factors such as damp,
mould, and pollutants (for example, volatile organic
compounds and combustion byproducts from heating
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aggravating the symptoms of asthma.
10 The relative
importance of these factors together with house dust
mites in causing asthma and aggravating symptoms
such as cough and wheeze is difficult to establish and
the pathophysiology remains unclear.
1112
Infants and elderly people spend proportionally
more time indoors
13 and children may be especially
vulnerable to indoor air pollutants that affect develop-
ment and lung function because of their immature
immunesystemsandrapidgrowthanddevelopment.
14
Infants and children also inhale a larger dose of air per
unit of body mass at a given level of activity and
therefore more pollutants than do adults in the same
environment.
15
Nitrogen dioxide has been widely used as a marker
foroutdoor airquality in studiesof pollutionrelatedto
vehicle emissions, but the most important source of
personal exposure to nitrogen dioxide is unflued gas
appliances.
16-18Pollutantsemittedindoorshaveabouta
1000-fold greater chance of being inhaled than those
emitted from proximate outdoor sources.
19-21 In New
Zealand a third of households have unflued gas
heaters
22 and previous studies have found that rooms
with such heaters have higher concentrations of
nitrogen dioxide than rooms with electric or flued gas
heaters.
23
Nitrogen dioxide is a proinflammatory gas and can
exacerbate respiratory symptoms such as wheeze or
cough. It can reduce immunity to lung infections and
increasetheseverityanddurationofanepisodeofflu.
24
Several cross sectional studies have investigated the
impact of home heating on morbidity, mostly respira-
tory symptoms in children.
2526 Reports on the impact
of cooking by gas on asthma have conflicted; some
studieshaveshownatwofoldincreaseinprevalenceof
asthma among households that cook by gas,
2728
whereas others have found no difference.
2930 Some
studies have also established a link between type of
heating and respiratory symptoms in children.
31
Unflued gas heaters and cookers release water vapour
duringthecombustionprocessandmaypartlyexplain
thelinkbetweendampnessandsymptomsofasthma.
32
Relatively few intervention studies have examined
the effects of housing improvements on health and
fewer still have shown an impact on symptoms of
asthma.
3334 One study highlighted the difficulty of
implementingcommunitybasedinterventiontrialsfor
controlling asthma.
34 An intervention study that
involved removing unflued gas heaters from school
classrooms found a significant reduction in children’s
self reported asthma symptoms.
35 A before and after
studyofaninterventiontoreducedampinthehomesof
children with asthma found a significant and cost
effective reduction in respiratory symptoms, particu-
larly cough at night and the number of days off
school.
3637
We previously carried out a randomised controlled
trial of the effects on respiratory health of insulating
homes.
38 Although we did not look exclusively at
peoplewithasthmatheresultsindicatedthatevenbasic
housing interventions, such as retrofitting insulation,
canraiseindoortemperaturesandimproverespiratory
symptoms.
39 During the analysis of this study we
became concerned about the number of children with
asthma living in homes with ineffective heating. The
use of ineffective and polluting heating systems in
many New Zealand houses suggested that improved
heating might provide further health gains over and
abovethat ofinsulation.Weinvestigatedthe impact of
a heating intervention on symptoms of asthma in
children in homes that had been insulated before this
trial.
METHODS
We carried out a randomised controlled trial in which
baseline measures were collected in winter (June to
September) 2005. Households in the intervention
group were allocated a non-polluting, more effective
replacement heater (heat pump, wood pellet burner,
flued gas) before the follow-up winter of 2006. The
control group received a similar heater in 2007, after
the final data collection in 2006.
The study was carried out in five areas in New
Zealand—Porirua and the Hutt Valley in the North
Island and Christchurch, Dunedin, and Bluff in the
SouthIsland.HouseholdswererecruitedfromDecem-
ber 2004 to May 2005. We identified community
Exclusions (n=40):
  Failed to fill out consent form (n=35)
  Failed to indicate heater choice (n=4)
  Non-contactable (n=1)
Before randomisation (n=13):
  Moved (n=8)
  Withdrew (n=5)
Exclusions (n=27):
  Moved (n=9)
  Non-contactable (n=3)
  Child moved (n=1)
  Heating changed (n=2)
  No longer interested (n=2)
  Bereavement (n=1)
  Unknown withdrawals (n=9)
Exclusions (n=22):
  Moved (n=9)
  Non-contactable (n=1)
  No children with asthma (n=1)
  Heating changed (n=1)
  Unknown withdrawals (n=10)
Households assessed for eligibility (n=899)
Pre-winter 2005: households eligible and provisionally accepted (n=462)
Completed 2005 baseline requirements (n=422)
Randomised (n=409)
Intervention group: 200 participants Control group: 209 participants
Intervention group: 178 participants completed
at least one symptom diary, 2006
Failed to complete 2006 questionnaire
on child’s health (n=3)
Intervention group: 175 participants
completed all requirements
Control group: 182 participants completed
at least one symptom diary, 2006
Failed to complete 2006 questionnaire
on child’s health (n=8)
Control group: 174 participants
completed all requirements
Flow of households and children through study
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health organisations (five with close ties to Maori,
indigenousNewZealanderswhohaveagreaterburden
of respiratory illness). The community coordinators
invited families who had a child with asthma to
participate in the study. The study was also publicised
in radio interviews. Overall, 899 applications were
receivedofwhich422 (47%)met theinclusioncriteria:
the family lived in a study area and had a child aged
between 6 and 12 years with doctor diagnosed asthma
and symptoms in the past 12 months; the child slept at
least four nights a week in the house; the house
contained a less effective form of heating (unflued gas
or plug-in electric heaters); the family intended to live
in the house over the two winter periods; and the
homeowner agreed that the household could take part
inthestudy.Ifmorethanonechildina householdmet
the study criteria then the child whose birthday
occurred first after 1 June became the index child.
After enrolment and before winter 2005 participat-
ing houses were insulated to the current New Zealand
building code standard, as our previous study had
shown positive effects from insulation alone.
39 This
insulation was considered necessary to achieve con-
sistency of the thermal envelope between the partici-
pating houses.
Baseline outcome measures
The research team trained the community coordina-
torsintheinformedconsentprocedures,completionof
questionnaires and symptom diaries, use of Piko
meters (nSpire Health, Longmont, CO) for measuring
peak expiratory flow rate and forced expiratory
volume in one second (FEV1), and correct placement
of temperature loggers and nitrogen dioxide diffusion
tubes. At the end of winter 2005 the community
coordinators assisted households in completing the
questionnaires. To check for reporting bias we
included three outcomes for which we hypothesised
no association with the intervention: diarrhoea,
vomiting, and ear infections. The questionnaires are
availableatwww.wnmeds.ac.nz/healthyhousing.html.
Children kept daily diaries of their respiratory
symptoms, giving a score from 0 to 3 for each of six
lower respiratory tract symptoms and each of five
upperrespiratorytractsymptoms,asusedinaprevious
study.
24 They also recorded the number of puffs of
asthmapreventerandrelieverdrugsdailyandwhether
a reliever was used at night. The community coordi-
nators downloaded data from the Piko meters on to
laptops at each of four monthly visits. The diffusion
tubesforrecordingnitrogendioxidelevelswereplaced
in a safe, standard location in the living room and
child’sbedroom(1.8mfromthegroundand5cmfrom
the wall). Temperature loggers, positioned on the
diffusiontubeholders,recordedthetemperatureevery
20 minutes. The diffusion tubes and temperature
loggers were changed at each visit.
Intervention
The advantages and disadvantages of the three heater
types (heat pump, wood pellet burner, or flued gas)
were explained at community meetings and described
on the research group’s website. The homeowners
chose a replacement for their existing heaters. Land-
lords were encouraged to consider their tenants’
preferences. An independent statistician then rando-
mised the households to intervention or control
groups, stratified by area and heater choice. The
heaterswereinstalledintheinterventionhousesbefore
winter 2006. The control group were told that they
would receive a replacement heater at the end of the
study.
Outcome measurements
Baselinemeasureswererepeatedaftertheintervention
at follow-up in winter 2006. In 2006 we changed the
formatofthequestionnaire,eliminatingtheinstruction
that if people answered no to the question on wheeze
they were to skip related questions, and we added a
question on twisted ankles to check for reporting bias.
Wechangedthemethodofrecordingthedatafromthe
Pikometertorecordingreadingsinthesymptomdiary,
asthedownloadeddatafrom2005wereunsatisfactory.
The temperature loggers were reprogrammed to
record temperature every hour instead of every
20minutesandtoremaininplaceforthewholewinter.
We re-emphasised to the community coordinators the
need for accuracy and timely retrieval of data.
Participants signed informedconsent forms. Parents
signed on behalf of their children. Households were
told that the heaters were the property of the home-
owner.
Outcomes and sample size
The primary outcome measure was changes to lung
function.Thestudywaspoweredtoshowareductionin
the amplitude of diurnal changes, expressed as a
percentage of their mean peak expiratory flow rate
overwinter(amplitude%mean).Atotalof430children
Table 1 |Comparisonbetweenchildrenwithasthmaininterventionandcontrolgroups.Valuesare
percentages(numbers)unlessstatedotherwise
Variables
Intervention group
(n=175)
Control group
(n=174)
Mean difference
(95% CI)
Boys 54.29 (95) 60.34 (105) −6.05 (−16.99 to 4.87)
Mean (No) age (years) 10.06 (175) 10.02 (174) 0.04 (−0.23 to 0.30)
Ethnicity:
Ma ¯ori 34.86 (61) 37.36 (65) −2.50 (−13.15 to 8.15)
Pacific peoples 13.14 (23) 7.47 (13) 5.67 (−0.01 to 12.60)
Other 52.00 (91) 43.68 (76) 8.32 (−2.70 to 19.34)
Family history of asthma 53.71 (94) 54.02 (94) −0.31 (−11.08 to 10.46)
Smoker in home 20.00 (35) 22.41 (39) −2.41 (−6.7 to 11.56)
Region:
Porirua 21.71 (38) 22.41 (39) −0.7 (−9.97 to 8.57)
Hutt Valley 33.71 (59) 28.74 (50) 4.97 (−5.30 to 15.26)
Christchurch 27.43 (48) 28.57 (50) −1.31 (−11.31 to 8.69)
Dunedin and Bluff 17.14 (30) 20.11 (35) −2.97 (−11.71 to 5.77)
Gasheatingbeforestudy 55.43 (97) 59.20 (103) 3.77 (−7.18 to 14.71)
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intervention group compared with the control group,
assuming a correlation with the previous year’s
measurement of 0.4, with 90% power, α at 0.05, and a
15% non-response rate. Secondary outcomes were
reported asthma symptoms, scores for lower respira-
torytractsymptomsfromthe diaries,asthmadruguse,
healthcare utilisation, and days off school. Inter-
mediate outcomes were temperature and nitrogen
dioxide levels in the living room and child’sbedroom.
Statistical analysis
Epi-Info version 3.4.1 (Centers for Disease Control and
Prevention, Atlanta, GA) was used to double enter the
responsestothequestionnaireanddatafromthediaries.
We cleaned and analysed the data using the statistical
package R version 2.4.1 (www.r-project.org/). The
binary information (for example, dry cough at night
yes or no) was analysed using bothstandard generalised
linear models and analysis of covariance (adjusting for
outcome at baseline) generalised linear models with the
logistic link function. From these models we derived
unadjusted odds ratios (95% confidence intervals) as
measures of effect size and adjusted odds ratios (95%
confidence intervals) as measures for precision of
estimates. We similarly analysed the numerical counts
(for example, number of days off school) but with a
Poisson link function. For these models we present the
change for the intervention group compared with the
control group as mean number of events, with 95%
confidence intervals.
Wepresentdataonlyfortheindexchild,eliminating
the need to control for clustering by household. When
baselinemeasurementswerenotavailable(0%to2%of
participants for questionnaires, 24% for symptom
diaries, and 33% for lung function measures), we used
the overall mean and validated the results using the
complete data. Results for the interpolated data were
predominantly within 5% of the results for the non-
interpolated data.
In the daily diaries individual respiratorysymptoms
were recorded on a nominal scale (0 to 3) as used
previously.
24 We combined the results for the three
questionsoncoughandthethreeonwheeze(morning,
day,andnight)togiveascoreforcoughandascorefor
wheeze,eachonascaleof0to9.Thesesixquestionson
lower respiratory tract symptoms were also combined
to give a score on a scale of 0 to 18, and the five
questions on upper respiratory tract symptoms were
likewise combined to give a score on a scale of 0 to 15.
WemeasuredFEV1andpeakexpiratoryflowratefrom
three good forced expiratory manoeuvres, measured
each morning and evening. The three outcomes
presented are the best blow in the morning, in the
evening, and that day.
For all daily records we used a linear mixed model
40
(lmer function in R lme4 library). This model uses two
levels: in the first level (intraindividual) each child’s
sequenceofdailyresponsesismodelledbyanintercept
term, on the next level (interindividual) the inter-
vention is then evaluated for its effect on this intercept
term. The model finds the estimate of effect size that
maximises the model likelihood as given by a
distribution function. We used a Poisson distribution
tomodelthedailysymptomscoresandtheircombina-
tions and the number of puffs for preventer and
Table 2 |Effectofinterventiononlungfunctioninchildren
Variable
No of
person
days
No of
children
Unadjusted Adjusted*
Effect size (β) (95% CI) P value Effect size (β) (95% CI) P value
Amplitude % mean peak
expiratory flow rate
26 439 359 1.41 (−2.80 to 5.62) 0.51 1.41 (−2.80 to 5.62) 0.62
Daily FEV1 26 960 360 130.7 (−20.3 to 281.7) 0.09 129.4 (−21.4 to 280.3) 0.09
Morning FEV1 22 157 346 57.6 (−74.8 to 190.1) 0.40 57.0 (−75.4 to 189.4) 0.4
Evening FEV1 23 406 353 121.7 (−37.0 to 280.3) 0.13 120.6 (−38.1 to 279.4) 0.14
Daily peak expiratory flow rate 27 007 360 12.29 (−4.57 to 29.15) 0.15 12.12 (−4.76 to 29.00) 0.16
Morning peak expiratory flow
rate
22 450 347 9.01 (−7.54 to 25.56) 0.28 8.92 (−7.66 to 25.50) 0.29
Evening peak expiratory flow
rate
23 413 353 12.30 (−4.14 to 28.74) 0.14 12.17 (−4.3 to 28.63) 0.15
Percentage predicted†:
FEV1 22111 283 2.46 (−11.62 to 16.54) 0.73 2.6 (−11.52 to 16.73) 0.72
Morning FEV1 18 465 276 −1.07 (−12.62 to 10.49) 0.85 −0.87 (−12.46 to 10.72) 0.88
Evening FEV1 19 279 280 2.60 (−12.00 to 17.20) 0.73 2.59 (−12.05 to 17.24) 0.73
Peak expiratory flow rate 22 139 283 3.54 (−1.41 to 8.48) 0.16 3.56 (−1.39 to 8.52) 0.16
Morningpeakexpiratoryflow
rate
18 613 276 2.99 (−1.77 to 7.75) 0.22 3.01 (−1.77 to 7.78) 0.22
Evening peak expiratory flow
rate
19 279 280 3.65 (−1.14 to 8.45) 0.14 3.68 (−1.13 to 8.49) 0.13
FEV1=forced expiratory volume in one second.
ß coefficients are estimated effect size of intervention on peak expiratory flow rate and FEV1.
*Controlled for baseline measure.
†Percentage of predicted FEV1 or peak expiratory flow rate based on 283 available heights.
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peak expiratory flow rate and FEV1.
We tested model distributions by examining the
dispersionvariableinthePoissonmodelsandQQplots
for the normal models. Ethnicity was collected using
thestandardisedselfidentityquestionofStatisticsNew
Zealand. When multiple ethnicities were reported we
used prioritised Mori and then Pacific ethnicities.
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RESULTS
Overall, 409 households were randomised. After
exclusions and withdrawals 349 (85%) households
remained (figure). After randomisation no significant
differences were found between intervention and
control groups for all relevant measured variables
(table 1).Ofhouseholdsthatcompletedthestudy,175
heaters were installed in the intervention group (131
heat pumps,39 wood pellet burners,and fiveflued gas
heaters). The three intervention households that with-
drew from the study had chosen heat pumps.
Table 2 shows the results for the lung function tests
doneinthemorningandevening.Theβcoefficientsare
the average daily change in best blow for FEV1 and
peak expiratory flow rate for the intervention group
compared with the control group. In 2006, after the
intervention, a non-significant increase occurred in
dailyFEV1(129.4ml,95%confidenceinterval−21.4to
280.3; P=0.09) and daily peak expiratory flow rate
(12.12 l/min, 95% confidence interval −4.76 to 29.00;
P=0.16).
Table 3 shows self reported health status and the
outcomes used to test for reporting bias. A statistically
significant improvement occurred in half the symp-
toms—that is, fewer children in the intervention group
than control group had health rated as suboptimal
(poor,fairvgood,verygood,excellent)bytheirparents
(adjustedoddsratio0.48,95%confidenceinterval0.31
to0.74;P<0.001).Parentalreportsshowedareduction
insleepdisturbedbywheeze(adjustedoddsratio0.55,
95%confidenceinterval0.35to0.85;P<0.001)anddry
cough at night (0.52, 0.32 to 0.83; P=0.01).The other
three symptoms (attacks of wheezing, speech limited
by wheeze,and wheezeduringexercise)improvedbut
not significantly. Of the four outcomes used to test for
reportingbias(diarrhoea,vomiting,earinfections,and
twistedankles)onlytwistedanklesshowedasignificant
effect.
Results from the daily symptom diaries are pre-
sented as mean ratios—the average score for the
intervention group divided by the average score for
thecontrolgroup(table 4).Theresultswereconsistent
withthoseofthequestionnairescompletedattheendof
winter, by showing a significant reduction in lower
respiratory tract symptoms (adjusted mean ratio 0.77,
95% confidence interval 0.73 to 0.81; P=0.013), cough
(0.75,0.62to0.92;P=0.005),andwheeze(0.67,0.50to
0.91;P=0.011).Anon-significantreductionoccurredin
theuseofrelieverduringthenight(adjustedoddsratio
0.55, 95% confidence interval 0.28 to 1.08; P=0.081).
Parents of children in the intervention group
reported fewer days off school for asthma during the
winter of 2006: 0.73 (95% confidence interval −0.67 to
1.94, P=0.28; see table 5). Statutory school records on
absence, however, showed that children in the inter-
vention group had 1.80 fewer days off school (0.11 to
3.13,P=0.04)duringthewinterterm(100schooldays).
Parents of children in the intervention group also
reported an average of 0.5 fewer episodes of cold and
flu (95% confidence interval 0.14 to 0.79, P=0.01), 0.4
fewer visits to the doctor for asthma (0.11 to 0.62,
P=0.01), 0.25 fewer visits to a pharmacist for asthma
(0.09 to 0.32, P=0.01), and 0.27 fewer visits to the
doctorfornon-asthmarelatedconditions(0.01to0.46,
P=0.04).
Exposure
After the intervention, during the winter of 2006, the
average living room temperature of intervention
households was 17.07°C compared with 15.97°C for
control households: a difference of 1.10°C (95%
confidence interval 0.54°Ct o1 . 6 7 °C, P<0.001).
Similarly, the average temperature in the child’s
bedroom for intervention households was 14.84°C
compared with 14.26°C for control households: a
Table 3 |Effectofheatinginterventiononparentreportedhealthoutcomesinchildren
Health outcome
No of
children
(n=349)
% with
outcome in
control group
Unadjusted Adjusted*
Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Poor or fair health† 346 60 0.46 (0.30 to 0.71) <0.001 0.48 (0.31 to 0.74) <0.001
Attacks of wheezing‡ 345 43 0.68 (0.44 to 1.05) 0.08 0.71 (0.45 to 1.11) 0.13
Sleep disturbed by wheeze 344 60 0.54 (0.35 to 0.83) 0.005 0.55 (0.35 to 0.85) <0.001
Speech limited by wheeze 344 19 0.74 (0.43 to 1.27) 0.27 0.69 (0.40 to 1.18) 0.18
Wheeze during exercise 344 66 0.73 (0.46 to 1.14) 0.16 0.67 (0.42 to 1.06) 0.09
Dry cough at night 345 66 0.50 (0.32 to 0.79) 0.003 0.52 (0.32 to 0.83) 0.01
Diarrhoea 343 34 0.81 (0.51 to 1.26) 0.34 0.72 (0.45 to 1.16) 0.18
Vomiting 344 31 1.01 (0.64 to 1.59) 0.98 0.88 (0.55 to 1.40) 0.58
Ear infections 344 24 1.40 (0.85 to 2.31) 0.19 1.16 (0.68 to 1.99) 0.58
Twisted ankles 346 12 1.86 (1.03 to 3.35) 0.04 —§ —§
*Controlled for baseline measure.
†Compared with good, very good, and excellent health.
‡More than four attacks per week compared with fewer than three attacks.
§Question not asked in 2005.
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0.05°C to 1.08°C, P=0.03).
Exposure to low temperatures, measured as degree
hours—thatis,hoursperday,multipliedbynumberof
degrees less than 10°C—was over 50% less in the
intervention group than control group. In the living
room the exposure was 1.13 degree hours in the
intervention group compared with 2.31 degree hours
in the control group, a difference of 1.18 degree hours
(95% confidence interval 0.49 to 1.93, P=0.001).
Exposure in the child’s bedroom was 2.03 degree
hours in the intervention group compared with 4.29
degree hours in the control group, a difference of 2.26
degree hours (0.99 to 2.34, P<0.001).
Ambient outdoor nitrogen dioxide levels were the
same in both groups, but indoor levels were signifi-
cantly reduced in the intervention group. In 2006 the
intervention group had significantly (P<0.001) lower
geometric mean nitrogen dioxide levels in the living
room than the control group (8.5 μg/m
3v 15.7 μg/m
3,
P<0.001). A similar significant effect was found in the
child’s bedroom (7.3 μg/m
3v 10.9 μg/m
3, P<0.001).
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DISCUSSION
Installing non-polluting, more effective home heating
in the households of children with asthma in New
Zealanddidnotsignificantlyimprovelungfunctionbut
did lead to a reduction in symptoms of asthma,
improved wellbeing, and fewer days off school.
The housing, heating, and health study was a
community based trial on the impact of improved
heating on the health of children with asthma. The
study received funding from both the public and the
private sector. We used a partnership model that
entailedworkingwith18differentcommunityagencies
andprivateorganisationsandwewereabletomaintain
a high level of support throughout. This study also
showed the success of a treaty based partnership
research design, which saw involvement and respon-
sibility of Maori at all levels of the research thus
facilitating the participation of Maori community
organisations and participants.
We used lung function as the primary outcome
measurebecauseitcanbeobjectivelyrecorded.Wedid
not, however, find a statistically significant improve-
ment in either FEV1 or peak expiratory flow rate. One
possible reason for failing to achieve statistical sig-
nificance is that the improvement in symptoms led to
lessuseofrelieverdrugsandthisintroducedabiasthat
reduced the observed effect on lung function.Another
possibility is an error in our measurement of lung
function;thePikometerprovedsusceptibletounstable
readings with poor technique. In the second year we
were aware of this limitation and the community
workers took greater care to check the children’s
technique at each visit. Problems of this type reduce
statistical power but are unlikely to change the
direction of the result because of the randomised
nature of the study design. Another possible reason is
that the magnitude of the effect from the intervention
wassmallerthenanticipatedinourpowercalculations.
A possibility remains that no effect exists.
Although improvement in lung function is consid-
ered ideal for assessing control of asthma, little
correlation exists between measures of airway calibre
and symptoms of asthma,
43 nor is there good agree-
ment between asthma severity as reported by a doctor
or as determined by lung function.
44 Indeed, ques-
tionnaires to determine the control of asthma have
been shown to be better discriminators of control than
diaries of peak flow measurements.
45
Table 4 |Effectofheatinginterventionondailydifferencesofasthmasymptomsanddruguseasreportedindailydiaries
Variable
No of person
days No of children
Unadjusted Adjusted*
Mean ratio† (95% CI) P value Mean ratio† (95% CI) P value
Lower respiratory
tract symptoms
23 475 345 0.83 (0.66 to 1.05) 0.12 0.77 (0.73 to 0.81) 0.01
Cough at night 26 532 352 0.80 (0.63 to 1.00) 0.05 0.72 (0.59 to 0.89) 0.002
Wheeze at night 26 407 351 0.78 (0.54 to 1.12) 0.18 0.67 (0.49 to 0.93) 0.02
Cough on waking 26 514 352 0.74 (0.58 to 0.94) 0.02 0.67 (0.53 to 0.84) <0.001
Wheeze on waking 26 417 351 0.68 (0.49 to 0.94) 0.02 0.60 (0.45 to 0.81) 0.001
Cough during day 27 348 365 0.90 (0.75 to 1.10) 0.31 0.84 (0.70 to 1.01) 0.06
Wheeze during day 27 117 363 0.85 (0.61 to 1.17) 0.32 0.78 (0.59 to 1.04) 0.09
Cough symptoms 23 713 349 0.82 (0.67 to 1.02) 0.08 0.75 (0.62 to 0.92) 0.005
Overall wheeze
symptoms
23 532 345 0.76 (0.54 to 1.07) 0.11 0.67 (0.50 to 0.91) 0.01
No of reliever puffs 27 261 364 0.73 (0.46 to 1.14) 0.17 0.68 (0.44 to 1.05) 0.08
Reliever use at
night (yes or no)‡
26 725 352 0.52 (0.24 to 1.13) 0.10 0.55 (0.28 to 1.08) 0.08
No of preventer
puffs
27 567 363 1.05 (0.61 to 1.8) 0.87 1.08 (0.67 to 1.74) 0.74
Upper respiratory
tract symptoms
26 844 360 0.95 (0.76 to 1.19) 0.65 0.92 (0.74 to 1.14) 0.43
*Adjusted for baseline outcome.
†Average score for intervention group divided by average score for control group.
‡Binary model used and results presented as odds ratio.
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improvementsinlungfunction,thedirectionofalmost
all the results was towards an improvement in health.
We found significant reductions in asthma symptoms
and time lost from school and reductions in dry cough
at night and sleep disturbed by wheeze. These
reductions in nocturnal symptoms were supported by
similar findings from the children’s daily symptom
diaries.Thesechangesare consistentwithsignificantly
reduced exposure to nitrogen dioxide at home in the
eveningandatnight.Theuseofrelieverdrugswasalso
reducedatnightandduringthedayamongchildrenin
the intervention group compared with children in the
control group, although this also failed to reach
statistical significance.
Parents reported fewer lower respiratory tract
symptoms in children in the intervention group as
well as fewer absences from school and visits to the
doctor or a pharmacist for asthma, colds, and flu.. The
greater magnitude of changes in these symptoms and
behaviours compared with measured lung function
suggeststhatthesymptomsassociatedwithexposureto
nitrogen dioxide may have been predominantly of an
irritant nature rather than inducing changes in airway
calibre.
The results of this study build on earlier research
indicating that higher indoor temperatures and lower
nitrogen dioxide delivered by improved heating are
associated with reduced asthma symptoms
37 and our
ownworkshowingthatretrofittinginsulationinhomes
improves health status and respiratory symptoms.
39
Over and above the improvements in health already
obtainedfrominsulatingthesehouses,ourresultsshow
the impact of less polluting, more effective heating on
children’s self reported severity of asthma symptoms.
The reduction of symptoms is reflected in fewer days
off school and fewer visits to the doctor.
Although only half the houses in each group had
unflued gas heaters at baseline, the large reduction in
nitrogen dioxide levels in the intervention group
suggests a dual benefit of the new heaters: raising the
indoor temperature and reducing nitrogen dioxide
levels. Further analyses of nitrogen dioxide measure-
ments and the use of the new heaters are being
undertaken for a subsample of 69 intensively mon-
itored houses. In addition we are analysing the health
records of other family members to see if the inter-
vention had an impact on other dimensions and
objective measures of health, and we are carrying out
a cost benefit analysis. The capital cost of the study
interventionwasnotbornebytheparticipantsandwas
relatively high for a population based intervention
($NZ3000; £1137; €1392; $2007 average per house)
compared with the average cost of the unflued gas or
portable electric heater ($NZ100 per house).
Themajorlimitationinrandomisedtrialsofthissort
is the impossibility of implementing blinding of the
participants or field workers, once they visited the
home. This could have resulted in a reporting bias,
although as all participants knew at the outset of the
study that they would receive new heaters it is unclear
in which direction this would be. However, the
outcome measurements included both self report and
blinded measures and when both were available, as
with days off school, the blinded measures showed a
greater effect, suggesting any reporting bias was in the
direction of minimising the intervention effect. In
addition, three of the four questions that tested for
reporting bias were not significantly affected by the
intervention. The other outcome (twisted ankles)
showed increased reporting in the intervention
group,alsosuggestingthatanybiaswasinthedirection
of minimising the effect of the intervention.
Another important issue is the choice of primary
outcome measure; we chose lung function because it
wasmoreobjectiveandbecausethestudycouldnotbe
double blinded. It may be that lung function is less
importanttothedailylifeofchildrenwithasthmathan
are the frequency and severity of symptoms. In
addition symptoms may be more sensitive to change
and more reliable than laboratory based measures
carried out by children in a community setting.
Ashighlightedbyonestudy,managingacommunity
trial with community organisations as partners is
Table 5 |Effectofheatinginterventiononparentalreportsofhealthcareutilisationanddaysoffschool
Variable
No of
children
(n=349)
Mean
occurrence
per child in
control group
Unadjusted Adjusted*
Reduction due to
intervention (95% CI) P value
Reduction due to
intervention (95% CI) P value
Days off school (school
records)
267 9.47 1.55 (0.33 to 3.12) 0.10 1.80 (0.11 to 3.13) 0.04
Days off school (self report) 333 6.67 0.93 (−0.67 to 2.2) 0.23 0.73 (−0.67 to 1.94) 0.28
Visits to doctor for asthma 323 1.33 0.31 (−0.04 to 0.57) 0.07 0.40 (0.11 to 0.62) 0.01
Episodes of colds or flu 341 2.39 0.50 (0.14 to 0.79) 0.01 0.50 (0.14 to 0.79) 0.01
Other visits to doctor 333 1.08 0.24 (−0.05 to 0.45) 0.10 0.27 (0.01 to 0.46) 0.04
Visits to nurse for asthma 335 0.38 0.07 (−0.22 to 0.22) 0.54 0.05 (−0.24 to 0.2) 0.67
Visits to pharmacist for
asthma
345 0.37 0.26 (0.1 to 0.32) 0.01 0.25 (0.09 to 0.32) 0.01
Visits to after hours clinic for
asthma
348 0.12 0.01 (−0.12 to 0.07) 0.90 0.00 (−0.12 to 0.07) 0.92
Othervisitstoafterhoursclinic 345 0.16 0.07 (−0.08 to 0.12) 0.26 0.07 (−0.07 to 0.13) 0.22
*Controlled for baseline measure.
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34Forexample,manypeople
did not know initially whether their house was
insulatedorwhatkindofheatingtheyhad,sothevisits
by community coordinators before the study to
establishwhetherparticipantsmettheinclusioncriteria
weremorechallengingandexpensivethananticipated.
The study had some methodological difficulties; in
particular during the 2005 baseline year the Piko
meters did not perform as well as we had expected.
They proved fragile, were prone to recording high
readings with misuse, and the data were difficult to
download. In 2006 we amended the study protocol by
asking the children to write each measurement from
the Piko meter in the symptom diary and encouraged
the community workers to check these carefully to
ensure compliance and technique. To remind the
children to use their meters and diaries we gave them
digital alarm clocks and fridge magnets and stickers
with cartoon characters, which worked well. On the
final visit we gave each child a certificate of apprecia-
tion.
Theresultssuggestthatimprovingboththetypeand
amountofheatinginthehomesofchildrenwithasthma
doesnotsignificantlyaffectmeasuredlungfunctionbut
does have several beneficial effects. Houses in this
study included all forms of tenure, and the households
had a range of incomes, so apportioning the relative
benefitsto the participantsand to the public good is an
important policy issue. In the United Kingdom,
Scotland has made the policy decision that installing
central heating in all social and pensioner housing,
regardlessoftenure,islargelyforthegoodofthepublic
and will pay more health dividends than focusing on
clinical waiting lists, as is done in England.
46 The
heatersusedinthisstudywerenon-pollutingandmore
environmentally sustainable than the less effective
heaters that were replaced, an additional public good
benefit in terms of mitigating climate change.
47
Conclusion
Although the improvement in lung function was not
statistically significant, large improvements were
found in the symptoms of asthma. These patient
centred measures are arguably as important to the
daily life of children with asthma as more objective
measures, and adopting this environmental inter-
vention is an effective adjunct to the pharmaceutical
treatment of asthma symptoms.
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